Soejima Kyoko, Stevenson William G
Cardiovascular Division, Department of Internal Medicine, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA.
Curr Cardiol Rep. 2003 Sep;5(5):364-8. doi: 10.1007/s11886-003-0092-2.
Radiofrequency ablation is a valuable adjunctive therapy to implantable defibrillators in patients with recurrent monomorphic ventricular tachycardia (VT) after myocardial infarction. Episodes of VT are markedly reduced in most patients, and the major complications are less than 5%. Newer approaches allow successful ablation even when VT is unstable, and when multiple VTs are present. Epicardial mapping and ablation are needed in some patients. Continued advances in technology can be expected to further improve results.
对于心肌梗死后复发性单形性室性心动过速（VT）患者，射频消融是植入式除颤器的一种有价值的辅助治疗方法。大多数患者的室性心动过速发作明显减少，主要并发症少于5%。即使室性心动过速不稳定或存在多个室性心动过速时，新的方法也能成功进行消融。一些患者需要进行心外膜标测和消融。技术的不断进步有望进一步改善治疗效果。
